| Literature DB >> 33583685 |
Divya Kanchibhotla1, Peeyush Sharma2, Saumya Subramanian3.
Abstract
BACKGROUND: Medical science is increasingly recognizing the role of gut health in achieving optimal wellbeing. A healthy gut improves digestion. Additionally, it has a positive impact on multiple physiological networks such as immune system, central nervous system and hepato-endocrine system, thus contributing to the overall quality of life. Functional gastrointestinal disorders: also known as disorders of gut-brain interaction, such as irritable bowel syndrome are increasing worldwide. Conditions like stress, anxiety and mental disorders are correlated with these disorders. Mind-body interventions have been shown to ameliorate stress, anxiety and related conditions that may aggravate functional gastrointestinal disorders.Entities:
Keywords: Gastrointestinal disorder; Gut health; Vaishvanara Agni meditation
Year: 2021 PMID: 33583685 PMCID: PMC8039347 DOI: 10.1016/j.jaim.2021.01.006
Source DB: PubMed Journal: J Ayurveda Integr Med ISSN: 0975-9476
Participants demographic details (N = 54) n(%).
| Characteristics | Type | Participants |
|---|---|---|
| Gender n (%) | Male | 26(48.2) |
| Female | 28 (51.8) |
Mean value, SD and significance of GIQLI scores pre, day 24 and day 50 of intervention for the total population.
| Scale | Overall GIQLI Score | Core Symptoms | Psychological aspect | Physical aspect | Social aspect | Disease specific |
|---|---|---|---|---|---|---|
| Pre (Mean And Sd) | 84.9 ± 18.3 | 19.6 ± 6.1 | 13.7 ± 3.7 | 12.2 ± 6.0 | 2.4 ± 1.5 | 21.3 ± 4.2 |
| Day 24 (Mean And Sd) | 93.9 ± 18.5 | 24.2 ± 6.1 | 14.7 ± 3.2 | 14.1 ± 5.9 | 2.3 ± 1.6 | 22.3 ± 4.8 |
| Day 50 (Mean And Sd) | 97.9 ± 19.4 | 25.5 ± 6.2 | 15.1 ± 3.3 | 16.1 ± 5.4 | 1.9 ± 1.5 | 22.8 ± 5.3 |
| p value (Pre-Day 24) | 0.00∗∗ | 0.00∗∗ | 0.02∗ | 0.01∗ | 0.60 | 0.13 |
| p value (Pre-day 50) | 0.00∗∗ | 0.00∗∗ | 0.00∗∗ | 0.00∗∗ | 0.02∗ | 0.04∗ |
**p value <0.001. *p value <0.05.
Mean value and significance of GIQLI scores pre, day 24 and day 50 of intervention.
| Scale | Overall GIQLI Score | Core Symptoms | Psychological aspect | Physical aspect | Social aspect | Disease specific | |
|---|---|---|---|---|---|---|---|
| Male | Pre (Mean And Sd) | 91.2 ± 16.9 | 21.4 ± 5.4 | 14.9 ± 2.9 | 14.5 ± 5.6 | 2.3 ± 1.2 | 25.5 ± 4.5 |
| Day 24 (Mean And Sd) | 102.5 ± 12.5 | 26.4 ± 4.8 | 15.5 ± 2.6 | 16.9 ± 3.9 | 1.6 ± 1.3 | 24.5 ± 3.9 | |
| Day 50 (Mean And Sd) | 103.7 ± 17.7 | 27.1 ± 6.3 | 15.6 ± 3.1 | 17.2 ± 4.3 | 1.7 ± 1.5 | 27.5 ± 5.7 | |
| p value (Pre-Day 24) | 0.00∗∗ | 0.00∗∗ | 0.01∗ | 0.00∗∗ | 0.04∗ | 0.02∗ | |
| p value (Pre-day 50) | 0.00∗∗ | 0.00∗∗ | 0.04∗ | 0.00∗∗ | 0.03∗ | 0.06 | |
| Female | Pre (Mean And Sd) | 80.62 ± 18.2 | 18.28 ± 6.3 | 12.31 ± 3.5 | 10.6 ± 5.8 | 2.4 ± 1.7 | 23.6 ± 5.3 |
| Day 24 (Mean And Sd) | 88.06 ± 19.8 | 22.59 ± 6.5 | 13.3 ± 3.08 | 12.1 ± 6.2 | 2.7 ± 1.6 | 23.6 ± 5.5 | |
| Day 50 (Mean And Sd) | 93.93 ± 19.7 | 24.3 ± 6.0 | 13.8 ± 3.07 | 15.3 ± 5.9 | 2 ± 1.5 | 25.0 ± 6.1 | |
| p value (Pre-Day 24) | 0.04∗ | 0.00∗∗ | 0.44 | 0.40 | 0.20 | 0.97 | |
| p value (Pre-day 50) | 0.00∗∗ | 0.00∗∗ | 0.02∗ | 0.00∗∗ | 0.29 | 0.32 |
**p value <0.001. *p value <0.05.
Cohen’s d value.
| Domain | D0-D24 | D0-D50 |
|---|---|---|
| GI QLI Index | 0.489 | 0.689 |
| core symptom | 0.753 | 0.958 |
| Psychological aspect | 0.294 | 0.391 |
| Physical aspect | 0.317 | 0.688 |
| Social aspect | 0.083 | 0.341 |
| Disease specific | 0.205 | 0.298 |